Michigan State University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Michigan State University sits in the top decile of US sponsors by registered trial count (#217 of 15,742 sponsors by registered trial count).
Michigan State University: 120 sponsored US clinical trials, 24 recruiting.
Michigan State University sponsors 120 registered US clinical trials on ClinicalTrials.gov, 24 of them currently recruiting, and 79 completed. 4 of these trials are in Phase 3-4 (later-stage) and 14 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Vaccine-Preventable Diseases, with 2 trials.
Top-decile sponsor footprint
Michigan State University ranks in the top decile of sponsors by registered trial count (#217 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
79 of 86 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
120 total, page 2 of 3
Culturally-Targeted COVID-19 Communication and SARS-CoV-2 Antibody Testing Evaluation and Uptake
NCT04957082
Diabetes Education and A1c Study
NCT04806685
Assessment of a Fruit and Vegetable Prescription Program for Children
NCT04767282
Effects of Open-label Placebos on COVID-related Psychological Health
NCT05035550
Subantimicrobial Doxycycline in Acne
NCT05399290
Telehealth CBT for Adolescents and Young Adults With Childhood-onset Systemic Lupus Erythematosus
NCT04335643
Team Science to Promote Physical Activity
NCT03906942
The Men Are Now United Program
NCT03208686
MyT1DHero: an mHealth Intervention for Type 1 Diabetes
NCT03521362
The ASSET Program for Youth With ASD
NCT06535191
Over-the-counter (OTC) Labels for Older Adults
NCT04345731
Neural Mechanisms of Treatment Response to ADAPT
NCT03518216
Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise
NCT04292535
Minimum Intervention to Maintain a Postpartum Depression Prevention Program in Clinics Serving Low-income Women
NCT03267563
Using an mHealth App to Transition Care of Type-1 Diabetes From Parents to Teens
NCT03436628
Design Factors for Evaluating Child Resistant Packaging
NCT03925623
Effects of Bright Light on Co-occurring Cancer-related Symptoms in Breast Cancer Survivors
NCT03304587
The Effect of OMT on Functional Outcomes and Anti-inflammatory Biomarkers in Mild to Moderate Traumatic Brain Injury
NCT03163901
Breastfeeding Support and Weight Management for Black Women
NCT03480048
Using SMART Design to Improve Symptom Management Strategies Among Cancer Patients
NCT02759146
Suicide Prevention Intervention for At-Risk Individuals in Transition
NCT02759172
Using Video Gaming to Evaluate Front of Pack Labeling With Children
NCT03482336
Michigan Stroke Transitions Trial
NCT02653170
Vaccination Responses in Young and Older Adults
NCT02654704
Effectiveness of Differing Levels of Support for Family Mealtimes on Obesity Prevention Among Head Start Preschools
NCT02487251
Improving Care for Youth With FAP: A Stepped Care CBT Delivery Approach
NCT03134950
Comparative Efficacy of Self-directed & Therapist-assisted Telehealth Parent Training Intervention for Children With ASD
NCT02721381
Biological Triggers of Depression in Pregnancy
NCT02566980
Quantifying the Attentive Behaviors of Older Adults During Over-the-counter Drug Selection
NCT02188134
Vaccination Response in Individual Monozygotic Twins
NCT02296359
Intrauterine Cleaning After Placental Delivery at Cesarean Section: RCT
NCT02152735
Effects of Osteopathic Manipulative Treatment on Neuromuscular Control of the Head-neck System
NCT02261259
Trunk Motor Control Performance Before and After Spinal Manipulation Treatment
NCT02261246
Tools For Teen Moms: Reducing Infant Obesity Risk
NCT02244424
Osteopathic Manipulative Treatment and Postural Control: Systems Engineering Approach
NCT02261233
Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine
NCT05378711
An Intervention to Promote Oral Agent Adherence and Symptom Management: ADHERE
NCT02337296
A Prospective Study of a Haptic Device Evaluation of the Acute Abdomen
NCT01982708
Drain Placement for Seroma Prevention After Mammosite/SAVI Catheter Removal
NCT02390661
Compex Use With Delayed Onset Muscle Soreness: A Comparison to Other Methods
NCT01967121
Visual Distraction as a Means of Enhancing Child Resistance
NCT01859780
Text Messaging to Improve Adherence to Oral Chemotherapy Agents
NCT01889511
Measurement of Blood Perfusion in Response to Loading in Patients With Wounds
NCT02082041
Study Response of 13-valent Conjugate Pneumococcal Vaccine in Patients With End Stage Renal Disease
NCT01974817
The Effect of OMT on Patients With COPD: Correlating Pulmonary Function Tests With Biochemical Alterations
NCT01582958
Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR
NCT02043184
Effect of hCG on Receptivity of the Human Endometrium
NCT01786252
The Symptom Experience Study in Persons With Non-Small Cell Lung Cancer
NCT01786187
Use of in Vivo 3T MR to Characterize Carotid Plaque in Patients and Correlate MR Findings With Symptoms
NCT02335567
Home-Based Symptom Management Via Reflexology for Breast Cancer Patients
NCT01582971
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 7 |
| Phase 4 | 4 |
Therapeutic Areas
What is open in the Michigan State University pipeline
24 recruiting of 120 indexed (20% open); 79 completed (66%).
Phase mix: 4 late (III/IV) vs 14 early (I/II) (early-phase heavy).
Top condition: Vaccine-Preventable Diseases (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Michigan State University: open-pipeline peers nationwide
Peers matched on 120 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Michigan State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 120 trials (± recruiting share)
- Children's Hospital Los Angeles · 119 trials · 29% recruiting
- Jaeb Center for Health Research · 119 trials · 14% recruiting
- Medtronic - MITG · 119 trials · 4% recruiting
- West Virginia University · 122 trials · 18% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
Related
What to do with this Michigan State University page
120 registered trials is a research-attention snapshot, not an endorsement of Michigan State University or any single study.
- 24 of Michigan State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Vaccine-Preventable Diseases is the condition Michigan State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Vaccine-Preventable Diseases trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Michigan State University pipeline card: 120 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.